Deals activity & trends in the health, pharma, and life sciences sectors | PwC's Next in Health

You must have a iHealthFlix subscription and be logged in to watch videos

Login or Subscribe

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with US Pharmaceutical & Life Sciences Deals Leader, Glenn Hunzinger and US Health Services Deals Leader, Nick Donkar, on the current deals activity impacting the health and pharma and life sciences sectors, including: 

  • Tailwinds that are driving sector deals activity and growth
  • Headwinds that pose challenges for deals activity
  • Factors that can influence merger and acquisition success
  • Deals landscape outlook 
Event Date: Monday, August 9, 2021

Speaker

Trine Tsouderos
Igor Belokrinitsky
Glenn Hunzinger
Nick Donkar

Company

PwC Health Research Institute
Strategy&, PwC
PricewaterhouseCoopers
PricewaterhouseCoopers

Event Webpage (Available for subscribers only)


Category(s): Pharmaceutical

Format

Podcast

Contact Speaker / Organization (Available for subscribers only)